These box office numbers do not include the cost of production or marketing costs. They also don't count the billions in merchandising that Disney has made over the last...Entertainmentread more
Stocks in Asia traded lower on Monday morning, as investors await the start of a Nasdaq-style technology board on the Shanghai Stock Exchange.Asia Marketsread more
Instagram began tests that hide "like" counts on posts. That means influencers who market products on Instagram will have to rely on different metrics to show success.Technologyread more
Peter Neupert worked for Microsoft and Amazon-backed Drugstore.com, where he got to know Jeff Bezos. He now advises start-ups.Technologyread more
Last week shows that oil prices are not the indicator for Middle East tensions they once were, and worries about global demand and growing U.S. production has changed that...Market Insiderread more
The firing of the tear gas was the latest confrontation between police and protesters who have taken to the streets for over a month to fight a proposed extradition bill and...China Politicsread more
Facebook Vice President David Marcus is the face of the company's Libra digital currency, but the original driving force was a 26-year-old female corporate-development...Technologyread more
Amazon's new policy for account suspensions doesn't go far enough to protect sellers from potentially unfair and wrongful suspensions, merchants say.Technologyread more
There is no end in sight to the Boeing 737 Max grounding after two fatal crashes, prompting airlines to rethink their growth plans.Airlinesread more
Gluskin Sheff's David Rosenberg is painting a painful picture for stocks as earnings season goes into full gear.Futures Nowread more
After a year of flooding, Midwest farmers face a stifling heat wave that's spreading across the U.S.Weather & Natural Disastersread more
The race for GlaxoSmithKline Plc's Indian Horlicks nutrition business is nearly over and one of two European consumer giants, Unilever Plc and Nestle SA, is likely to be the winner, media reports indicated.
The auction for the assets, including popular malt-based health drinks brands Horlicks and Boost, could fetch more than $4 billion, sources told Reuters previously. GSK owns a 72.5 percent stake in the business, GlaxoSmithKline Consumer Healthcare Ltd.
GSK is in exclusive talks with Unilever to strengthen its position in India, its most important emerging market, the Financial Times reported on Tuesday citing people familiar with the sales process.
Indian newspaper Times of India reported on Wednesday, citing sources, that Nestlé is close to buying Horlicks and other GSK consumer healthcare assets but will not merge the business with its own local unit, Nestlé India Ltd.
A spokeswoman for GSK India told Reuters on Wednesday that the company is conducting a strategic review of its nutrition brands in India and expects to conclude the process by 2018.
If either of these two companies win the auction, that would mean they beat out Coca-Cola, another likely suitor who has been looking to expand in emerging markets as growth in the United States slows.
Coke was shortlisted to join the final round of the auction, which began in September, but its interest cooled, FT reported, citing one person familiar with the sales process.
The $4 billion valuation is considered too steep by some analysts as the Indian market for so-called health drinks - mostly dietary supplements or flavour enhancers typically drunk with milk - is seeing a sharp slowdown in growth.
Horlicks is still very popular and comfortably dominates the health-drinks market in India, but urban Indian consumers are increasingly turning to healthier, less-sugary alternatives and natural products.
Last month Kraft Heinz agreed to sell its popular health-drink brands Complan and Glucon-D, along with a couple of other brands and factories, to Indian pharma and consumer company Zydus Wellness Ltd for 45.95 billion rupees ($648.6 million).
A spokesman for Nestle India told Reuters on Wednesday that the company would not comment on speculation. A spokeswoman for Unilever said the company would get back on the Reuters query seeking comment about the media articles.